How This Works
CJC-1295 NO DAC (Modified GRF 1–29) is a truncated GHRH analog with four amino acid substitutions that enhance stability against enzymatic degradation. It binds to GHRH receptors on pituitary somatotrophs, stimulating the synthesis and pulsatile release of endogenous growth hormone. Unlike exogenous GH administration, GHRH analogs preserve the physiologic feedback loop, resulting in more natural GH pulsatility. Clinical studies with related GHRH analogs (sermorelin) demonstrate sustained increases in growth velocity and IGF‑1 levels with chronic once‑daily therapy.
Potential Benefits & Side Effects
Observations from preclinical and clinical literature on GHRH analogs.
Stimulates pulsatile GH release and elevates IGF‑1 levels with chronic administration.
May support improvements in body composition, recovery, and sleep quality over extended protocols.
Preserves physiologic GH feedback mechanisms unlike exogenous GH.
Generally well tolerated; potential side effects include transient flushing, headache, dizziness, or injection‑site reactions.
Gradual dose titration helps minimize adverse effects.
Dosage Guide: http://help.datapeptides.com/en/articles/15074040-cjc-1295-no-dac-10mg-vial-dosage-protocol
Disclaimer:
The information provided in this article is for educational and informational purposes only and is not intended as medical advice. These statements have not been evaluated by the FDA or Health Canada. Peptides and other compounds discussed are intended for research purposes only and are not approved for human consumption unless prescribed by a licensed medical professional. Always consult your healthcare provider before starting any new protocol, supplement, or treatment.